Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Felodipine

From Wikipedia, the free encyclopedia
Medication of the calcium channel blocker type

Pharmaceutical compound
Felodipine
Clinical data
Trade namesPlendil
AHFS/Drugs.comMonograph
MedlinePlusa692016
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability15%
MetabolismHepatic
Onset of action2.5–5 hours
Eliminationhalf-life25 hours[1]
ExcretionRenal
Identifiers
  • (RS)-3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
CAS Number
PubChemCID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.149.305Edit this at Wikidata
Chemical and physical data
FormulaC18H19Cl2NO4
Molar mass384.25 g·mol−1
3D model (JSmol)
  • O=C(OCC)\C1=C(\N/C(=C(/C(=O)OC)C1c2cccc(Cl)c2Cl)C)C
  • InChI=1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3 checkY
  • Key:RZTAMFZIAATZDJ-UHFFFAOYSA-N checkY
  (verify)

Felodipine is a medication of thecalcium channel blocker type that is used to treathigh blood pressure.

It was patented in 1978, and approved for medical use in 1988.[2]

Medical uses

[edit]

Felodipine is used to treathigh blood pressure and stableangina.[1][3]

It should not be used for people who are pregnant, haveacute heart failure, are having aheart attack, have anobstructed heart valve, or have obstructions that blockbloodflow out of the heart.[1]

For people withliver failure the dose needs to be lowered, because felodipine is cleared by the liver.[1]

Adverse effects

[edit]

The only very common side effect, occurring in more than 1/10 people, ispain and swelling in the arms and legs.[1]

Common side effects, occurring in between 1% and 10% of people, include flushing, headache,heart palpitations, dizziness and fatigue.[1]

Felodipine can exacerbategingivitis.[1]

Interactions

[edit]

Felodipine is metabolized bycytochrome P450 3A4, so substances that inhibit or activate CYP3A4 can strongly effect how much felodipine is present.[1]

CYP3A4 inhibitors, which increase the amount of felodipine available per dose, includecimetidine,erythromycin,itraconazole,ketoconazole,HIV protease inhibitors, andgrapefruit juice.[1][4]

CYP3A4 activators, which decrease the amount of felodipine available per dose, includephenytoin,carbamazepine,rifampicin,barbiturates,efavirenz,nevirapine, andSaint John's wort.[1]

Mechanism of action

[edit]

Felodipine is acalcium channel blocker.[1] Felodipine has additionally been found to act as anantagonist of themineralocorticoid receptor, or as anantimineralocorticoid.[5]

Different calcium channels are present in vascular tissue and cardiac tissue; anin vitro study on human vascular and cardiac tissues comparing how selective various calcium channel blockers are for vascular compared to cardiac tissue found the following vascular/cardiac tissue ratios:mibefradil 41, felodipine 12;nifedipine 7,amlodipine 5, andverapamil 0.2.[6]: 172 

Chemistry

[edit]

Felodipine is a member of the 1,4-dihydropyridine class of calcium channel blockers.[6]: 20–21  It is a racemic mixture, and is insoluble in water but is soluble in dichloromethane and ethanol.[6]: 25 

History

[edit]

The Swedish company Hässle, a division ofAstra AB,discovered felodipine;[7] it filed a patent application in 1979 claiming felodipine as an antihypertensive drug.[8][9] Astra partnered this drug and others withMerck & Co. in the US under a 1982 agreement between the companies.[7] The drug was approved by the FDA in 1991 after a three-and-a-half-year review; the drug entered a very crowded market to included the other calcium channel blockersnifedipine,verapamil,nicardipine, andisradipine.[7] The FDA gave the drug a 1C rating, meaning that it found little difference between felodipine and the drugs already approved for the same use.[7]

In 1994 Astra AB and Merck changed their partnership to ajoint venture called Astra Merck,[10] and in 1998 Astra (by that time,AstraZeneca) bought out Merck's rights in the joint venture.[11]

The first generics became available in Sweden in 2003[12] and in the US in 2004.[13]: 155 

In April 2016, AstraZeneca announced that they were selling the right to market felodipine in China to China Medical System Holdings for $310 million; AZ would continue to manufacture the drug.[14]

Society and culture

[edit]

As of 2016, felodipine was marketed under many brand names worldwide: Auronal, Cardioplen, Catrazil, Dewei, Dilahex, Enfelo, Erding, Fedil, Fedisyn, Feldil, Felicipin, Felo, Felocard, Felocor, Feloday, Felodil, Felodin, Felodip, Felodipin, Felodipina, Felodipine, Felodipino, Felodistad, Felogard, Felohexal, Felop, Felopine, Felostad, Feloten, Felotens, Felpin, Flodicar, Flodil, Keliping, Keydipin, Lodistad, Modip, Munobal, Nirmadil, Parmid, Penedil, Perfudal, Phelop, Phenodical, Plendil, Plentopine, Polo, Presid, Preslow, Prevex, Renedil, Sistar, Splendil, Stapin, Topidil, Vascalpha, Versant, and XiaoDing.[15]

The combination of felodipine andcandesartan was marketed as Atacand.[15]

The combination of felodipine andramipril was marketed as Delmuno, Tazko, Triacor, Triapin, Triasyn, Tri-Plen, Unimax, and Unitens.[15]

The combination of felodipine andenalapril was marketed as Lexxel.[15]

The combination of felodipine andmetoprolol was marketed as Logimat, Logimax, and Mobloc.[15]

References

[edit]
  1. ^abcdefghijk"Felopidine UK label". UK Electronic Medicines Compendium. 15 September 2015. Archived fromthe original on 16 August 2019. Retrieved19 February 2015.
  2. ^Fischer J, Ganellin CR (2006).Analogue-based Drug Discovery. John Wiley & Sons. p. 465.ISBN 9783527607495.
  3. ^"Felodipine US label"(PDF). FDA. October 2012. Archived fromthe original(PDF) on 15 November 2016.
  4. ^Kiani J, Imam SZ (October 2007)."Medicinal importance of grapefruit juice and its interaction with various drugs".Nutrition Journal.6 (33) 33.doi:10.1186/1475-2891-6-33.PMC 2147024.PMID 17971226..
  5. ^Luther JM (September 2014)."Is there a new dawn for selective mineralocorticoid receptor antagonism?".Current Opinion in Nephrology and Hypertension.23 (5):456–461.doi:10.1097/MNH.0000000000000051.PMC 4248353.PMID 24992570.
  6. ^abcJoshi GS, Burnett JC, Abraham DJ (2003). "Cardiac Drugs: Antianginal, Vasodilators, Antiarrhythmic". In Abraham DJ (ed.).Burger's medicinal chemistry and drug discovery. Volume 3: Cardiovascular Agents and Endocrines (6th ed.). Hoboken, N.J.: Wiley.ISBN 9780471270904.
  7. ^abcd"Merck's Plendil (Felodipine) Approved with "1C" Rating".Pink Sheet. 5 August 1991.
  8. ^Astrazeneca AB v. Mutual Pharmaceutical Co. (United States Court of Appeals for the Federal Circuit 2004), Text.
  9. ^US patent 4,264,611, Berntsson P, Carlsson S, Gaarder J, Ljung B, "2,6-Dimethyl-4-2,3-Disubstituted Phenyl-1,4-Dihydro-Pyridine-3,5 Dicarboxylic Acid-3,5-Asymmetric Diesters having Hypotensive Properties, as well as Method for Treating Hypertensive Conditions and Pharmaceutical Preparations Containing Same", issued 28 April 1981, assigned to Aktiebolaget Hassle 
  10. ^George J (28 July 1997)."Secret of Astra Merck".Philadelphia Business Journal. Philadelphia. Retrieved7 November 2016.
  11. ^"Astra, Merck restructure".CNNMoney. 19 June 1998. Retrieved7 November 2016.
  12. ^Jönsson B (2008)."Sweden". In Rapoport J, Jacobs P, Jonsson E (eds.).Cost Containment and Efficiency in National Health Systems a Global Comparison. Weinheim: Wiley-VCH. p. 218.ISBN 9783527622955.
  13. ^Approved Drug Products with Therapeutic Equivalence Evaluations(PDF) (36th ed.). FDA. 2014.
  14. ^"AstraZeneca enters licensing agreement with China Medical System Holdings for hypertension medicine" (Press release). AstraZeneca. 29 February 2016. Retrieved7 November 2016.
  15. ^abcde"International brand names: Felodipine". Drugs.com. Retrieved15 November 2016.
Calcium
VDCCsTooltip Voltage-dependent calcium channels
Blockers
Activators
Potassium
VGKCsTooltip Voltage-gated potassium channels
Blockers
Activators
IRKsTooltip Inwardly rectifying potassium channel
Blockers
Activators
KCaTooltip Calcium-activated potassium channel
Blockers
Activators
K2PsTooltip Tandem pore domain potassium channel
Blockers
Activators
Sodium
VGSCsTooltip Voltage-gated sodium channels
Blockers
Activators
ENaCTooltip Epithelial sodium channel
Blockers
Activators
ASICsTooltip Acid-sensing ion channel
Blockers
Chloride
CaCCsTooltip Calcium-activated chloride channel
Blockers
Activators
CFTRTooltip Cystic fibrosis transmembrane conductance regulator
Blockers
Activators
Unsorted
Blockers
Others
TRPsTooltip Transient receptor potential channels
LGICsTooltip Ligand gated ion channels
MRTooltip Mineralocorticoid receptor
Agonists
Antagonists
CARTooltip Constitutive androstane receptor
PXRTooltip Pregnane X receptor
Retrieved from "https://en.wikipedia.org/w/index.php?title=Felodipine&oldid=1303148370"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp